This NIH R01 grant is specifically designed to support Clinical Observational (CO) Studies focusing on Musculoskeletal, Rheumatic, and Skin Diseases. It explicitly excludes clinical trials, focusing instead on rigorous observational research projects within these critical health areas. The grant aims to advance scientific understanding through non-interventional studies. This program announcement was re-issued to incorporate recent updates related to the ‘Simplifying Review of Research Project Grant Applications’, with changes exclusively made to Section V concerning simplified review processes. All other aspects and requirements of this funding opportunity remain consistent with previous iterations, ensuring continuity for applicants seeking to conduct significant observational research. The grant offers a substantial opportunity for researchers to contribute to the knowledge base of these complex diseases.
Opportunity ID: 357604
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-24-280 |
| Funding Opportunity Title: | Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.846 — Arthritis, Musculoskeletal and Skin Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 09, 2024 |
| Last Updated Date: | Dec 09, 2024 |
| Original Closing Date for Applications: | Nov 02, 2026 |
| Current Closing Date for Applications: | Nov 02, 2026 |
| Archive Date: | Dec 08, 2026 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments City or township governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education Public and State controlled institutions of higher education State governments Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-24-280.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 357604 Full Announcement-PAR-24-280 -> PAR-24-280-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289529 | Feb 04, 2025 | Nov 02, 2026 | View |
Package 1
Mandatory forms
357604 RR_SF424_5_0-5.0.pdf
357604 PHS398_CoverPageSupplement_5_0-5.0.pdf
357604 RR_OtherProjectInfo_1_4-1.4.pdf
357604 PerformanceSite_4_0-4.0.pdf
357604 RR_KeyPersonExpanded_4_0-4.0.pdf
357604 PHS398_ResearchPlan_5_0-5.0.pdf
357604 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
357604 RR_Budget_3_0-3.0.pdf
357604 RR_SubawardBudget30_3_0-3.0.pdf
357604 PHS398_ModularBudget_1_2-1.2.pdf
357604 PHS_AssignmentRequestForm_4_0-4.0.pdf